André Marette Selected Research

André Marette Research Topics

Disease

56	Insulin Resistance 01/2022 - 07/2002
53	Obesity 12/2022 - 07/2002
36	Inflammation (Inflammations) 01/2022 - 12/2010
19	Body Weight (Weight, Body) 12/2022 - 08/2011
14	Type 2 Diabetes Mellitus (MODY) 12/2022 - 05/2004
13	Glucose Intolerance 12/2022 - 07/2009
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 08/2011
7	Hyperinsulinism (Hyperinsulinemia) 12/2021 - 09/2005
6	Atherosclerosis 10/2021 - 12/2005
6	Weight Gain 10/2020 - 12/2010
6	Dyslipidemias (Dyslipidemia) 09/2020 - 05/2011
5	Overweight 12/2022 - 10/2015
5	Hyperlipidemias (Hyperlipidemia) 03/2022 - 06/2010
5	Neoplasms (Cancer) 01/2022 - 02/2010
5	Non-alcoholic Fatty Liver Disease 10/2021 - 05/2014
5	Metabolic Diseases (Metabolic Disease) 10/2020 - 07/2002
4	Weight Loss (Weight Reduction) 12/2020 - 04/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2015
4	Premature Aging 10/2018 - 01/2015
4	Werner Syndrome (Werner's Syndrome) 10/2018 - 01/2015
3	Prediabetic State (Prediabetes) 12/2022 - 01/2019
3	Abdominal Obesity 12/2022 - 05/2009
3	Hypertension (High Blood Pressure) 03/2022 - 04/2002
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 09/2020
3	Fatty Liver 01/2022 - 08/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2016
3	Aortic Valve Disease 10/2020 - 10/2014
3	Morbid Obesity 01/2020 - 12/2015
3	Endotoxemia 01/2020 - 12/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 11/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 02/2015
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2015 - 02/2002
2	Hypoxia (Hypoxemia) 01/2021 - 01/2011
2	Colitis 01/2021 - 01/2018
2	Dysbiosis 10/2020 - 12/2015
2	Aortic Valve Stenosis (Aortic Stenosis) 09/2017 - 05/2015

Drug/Important Bio-Agent (IBA)

51	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 10/2003
42	Insulin (Novolin)FDA Link 06/2022 - 07/2002
20	LipidsIBA 05/2022 - 02/2003
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
15	PolyphenolsIBA 12/2022 - 06/2015
10	Sucrose (Saccharose)IBA 04/2021 - 09/2002
8	Triglycerides (Triacylglycerol)IBA 12/2022 - 09/2013
7	Peptides (Polypeptides)IBA 03/2022 - 03/2014
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2004
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2021 - 02/2007
6	CholesterolIBA 01/2020 - 09/2013
6	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2011
6	CytokinesIBA 07/2015 - 07/2002
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2019
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 05/2010
5	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 05/2010
5	TOR Serine-Threonine KinasesIBA 03/2016 - 03/2005
5	Sirolimus (Rapamycin)FDA Link 03/2016 - 03/2005
5	Tyrosine (L-Tyrosine)FDA Link 03/2014 - 07/2002
4	AdiponectinIBA 01/2022 - 08/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 07/2002
4	Protein Tyrosine PhosphatasesIBA 01/2017 - 12/2009
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2011 - 05/2004
4	Amino Acids FDA Link 08/2007 - 09/2005
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 08/2008
3	Cholecalciferol (Vitamin D3)FDA Link 11/2021 - 09/2019
3	Vitamin D FDA LinkGeneric 10/2021 - 12/2015
3	Dietary Fats (Dietary Fat)IBA 01/2021 - 08/2009
3	10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA 01/2021 - 06/2014
3	Persistent Organic PollutantsIBA 12/2020 - 01/2020
3	SugarsIBA 07/2020 - 11/2016
3	PrebioticsIBA 01/2020 - 12/2015
3	C-PeptideIBA 09/2019 - 05/2014
3	CalciumIBA 01/2019 - 11/2017
3	DNA HelicasesIBA 10/2018 - 01/2015
3	Lipoproteins (Lipoprotein)IBA 09/2017 - 05/2011
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2015 - 06/2012
3	Rosiglitazone (Avandia)FDA Link 05/2014 - 08/2008
2	LDL CholesterolIBA 12/2022 - 06/2022
2	AcidsIBA 10/2021 - 01/2021
2	Dextran SulfateIBA 01/2021 - 12/2016
2	EnzymesIBA 01/2021 - 10/2015
2	Docosahexaenoic AcidsIBA 01/2021 - 01/2017
2	Dietary ProteinsIBA 01/2021 - 01/2007
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2013
2	Caseins (Casein)FDA Link 01/2021 - 08/2011
2	Fish OilsIBA 01/2021 - 07/2009
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2020 - 10/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2020 - 09/2020
2	FructoseIBA 07/2020 - 10/2003
2	CarbohydratesIBA 07/2020 - 07/2009
2	PowdersIBA 01/2020 - 12/2016
2	hydroxide ionIBA 09/2019 - 04/2019
2	PF-4708671IBA 01/2019 - 03/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2019 - 06/2010
2	EndotoxinsIBA 01/2018 - 12/2010
2	1- (diethylaminopropyl)- 4- phenylpiperazineIBA 01/2018 - 12/2016
2	lysophosphatidic acidIBA 09/2017 - 08/2015
2	ApolipoproteinsIBA 11/2016 - 05/2011

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2011
4	Oral Administration 01/2021 - 01/2016
2	Art Therapy 01/2022 - 09/2020
2	Glycemic Control 01/2021 - 08/2017
2	Fat-Restricted Diet (Diet, Fat Restricted) 12/2020 - 05/2015